Poland· PL-100539616
Triplixam
A medicinal product containing perindoprilum argininum + indapamidum + amlodipinum, registered in Poland by Medezin Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Perindoprilum argininum + Indapamidum + Amlodipinum
- Manufacturer
- Medezin Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991603670
- gtin05909991603687
- gtin05909991603694
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Perindoprilum argininum + indapamidum + amlodipinum in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandCoveram plus
- ItalyLOPRIDAMZENTIVA ITALIA S.R.L.
- SpainPERINDOPRIL/AMLODIPINO/INDAPAMIDA KRKA 7 MG/5 MG/2,5 MG COMPRIMIDOS EFGKrka D.D. Novo Mesto
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Perindopril/Indapamide/Amlodipine Eg
- Czechia · Perindopril Arginine / Indapamide/ Amlodipin Besilate Stada, Perindopril Arginine-Indapamide-Amlodipine Besilate Stada
- Luxembourg · Perindopril/Indapamide/Amlodipine Eg
- Slovakia · Perindopril/Indapamid/Amlodipín Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa769987-294a-48c4-9c39-a4427ce6bdc3 GET /v1/drugs/fa769987-294a-48c4-9c39-a4427ce6bdc3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "5 mg + 1,25 mg + 5 mg",
"packaging": "05909991603670 ¦ Rp ¦ 167423\n30 tabl.\n05909991603687 ¦ Rp ¦ 167424\n60 tabl.\n05909991603694 ¦ Rp ¦ 167425\n90 tabl.",
"substance": null,
"common_name": "Perindoprilum argininum + Indapamidum + Amlodipinum",
"pl_product_id": "100539616",
"pozwolenie_nr": "225/26",
"auth_procedure": "IR",
"authorisation_validity": "2031-06-11"
}See everything about perindoprilum argininum + indapamidum + amlodipinum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.